|
Market Closed -
Japan Exchange
02:30:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 580.00 JPY | -3.65% |
|
-2.68% | - |
| 08-21 | Certain Common Stock of Innovacell Inc. are subject to a Lock-Up Agreement Ending on 22-AUG-2026. | CI |
| 08-06 | Innovacell Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 27.18B 172M 153M 143M 130M 246M 16.57B 248M 1.73B 670M 8.47B 647M 633M | P/E 2026 * |
-7.39x | P/E 2027 * | -6.97x |
|---|---|---|---|---|---|
| Enterprise Value | 27.18B 172M 153M 143M 130M 246M 16.57B 248M 1.73B 670M 8.47B 647M 633M | EV / Sales 2026 * |
27.2x | EV / Sales 2027 * | 25.2x |
| Free-Float |
51.11% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.65% | ||
| 1 week | -2.68% | ||
| Current month | -8.23% | ||
| 1 month | +2.84% | ||
| 3 months | -9.80% | ||
| 6 months | -28.66% |
| 1 week | 572 |  | 643 |
| 1 month | 519 | | 643 |
| Current year | 377 | | 1,248 |
| 1 year | 377 | | 1,248 |
| 3 years | 377 | | 1,248 |
| 5 years | 377 | | 1,248 |
| 10 years | 377 | | 1,248 |
| Manager | Title | Age | Since |
|---|---|---|---|
Colin Lee Novick
CEO | Chief Executive Officer | 45 | 2022-02-28 |
Jason Sieger
CEO | Chief Executive Officer | 44 | 2025-02-28 |
Yasushi Hosono
DFI | Director of Finance/CFO | 59 | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Sieger
BRD | Director/Board Member | 44 | 2020-12-31 |
Colin Lee Novick
BRD | Director/Board Member | 45 | 2021-06-30 |
| Director/Board Member | 57 | 2021-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.65% | -2.68% | - | - | 172M | |
| +1.02% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -0.02% | -5.60% | +35.72% | +64.63% | 617B | |
| -0.36% | -0.58% | +12.36% | +77.95% | 464B | |
| -0.54% | -3.01% | +61.79% | +41.24% | 356B | |
| +0.74% | -1.97% | +20.80% | +41.22% | 333B | |
| +0.79% | -3.33% | +10.93% | +34.54% | 267B | |
| +0.24% | -4.96% | -6.71% | +8.90% | 244B | |
| -0.51% | -2.79% | +35.30% | +51.84% | 218B | |
| +0.01% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.26% | -2.79% | +26.08% | +58.78% | 369.74B | |
| Weighted average by Cap. | +0.30% | -3.54% | +29.09% | +70.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1B 6.34M 5.63M 5.26M 4.79M 9.04M 610M 9.12M 63.63M 24.66M 312M 23.8M 23.29M | 1.08B 6.83M 6.07M 5.67M 5.17M 9.74M 657M 9.83M 68.59M 26.58M 336M 25.66M 25.1M |
| Net income | -3.46B -21.96M -19.51M -18.21M -16.6M -31.3M -2.11B -31.59M -220M -85.38M -1.08B -82.44M -80.65M | -3.81B -24.14M -21.45M -20.02M -18.25M -34.42M -2.32B -34.74M -242M -93.89M -1.19B -90.65M -88.68M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-05 | JP¥580.00 | -3.65% | 68,900 |
| 26-10-02 | JP¥602.00 | -3.06% | 96,000 |
| 26-10-01 | JP¥621.00 | -1.74% | 96,500 |
| 26-09-30 | JP¥632.00 | +4.98% | 126,900 |
| 26-09-29 | JP¥602.00 | +1.01% | 79,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 504A Stock
Select your edition
All financial news and data tailored to specific country editions
